Clinical Trial Update: A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the safety and early signals of efficacy of IAP0971 in patients with advanced malignant tumors, including advanced or meta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• IAP0971

Snippet

Sponsor: SUNHO（China）BioPharmaceutical CO., Ltd. | Conditions: Advanced Malignant Neoplasm, Advanced or Metastatic Non-small Cell Lung Cancer | Phase 1, Phase 2 | Status: RECRUITING